Current 2011 Speakers*

Margaret Anderson, Executive Director, FasterCures

Anthony Atala, MD, Director, Wake Forest Institute for Regenerative Medicine

John A. Bardis, Founder, Chairman, President and Chief Executive Officer, MedAssets, Inc.

Frederick Blume, Managing Director, Excel Venture Management

Gregory A. Bonfiglio, Managing Director, Proteus Venture Partners

Steven Borst, Principal, Upstart Life Sciences Capital

Scott R. Burger, MD, Principal, Advanced Cell & Gene Therapy, LLC

Arnold I. Caplan, PhD, Professor, Case Western Reserve University

Chris Coburn, Executive Director, Cleveland Clinic Foundation Innovations

Raymond Cypess, DVM, PhD, Chairman, President and Chief Executive Officer, ATCC 

Ora Dar, PhD, Head of Life Sciences Sector, Israel Office of the Chief Scientist, Ministry of Industry Trade and Labor

Roy N. Davis, President, Johnson and Johnson Development Corporation

Aubrey de Grey, PhD, Chief Scientific Officer, SENS Foundation

Roland DeAngelis, Senior Director, Global Advocacy, Genzyme

Michael F. Elliott, Partner, Noro-Moseley Partners

Ellen Feigal, MD, Vice President, R&D, California Institute for Regenerative Medicine

Lisa Beth Ferstenberg, MD, Director of Consulting Services, Technical Resources International, Inc.

Richard A. Gephardt, President and Chief Executive Officer, Gephardt Government Affairs

Colonel Janet R. Harris, RN, PhD, Director, Clinical and Rehabilitative Medicine Research Program, US Army Medical Research and Materiel Command

Waleed Hassanien, MD, CEO, TransMedics, Inc

James H. Holmes IV, MD, Assistant Professor, Wake Forest Institute for Regenerative Medicine

Terry Irgens, RPh, MS, Director, Armed Forces Institute of Regenerative Medicine

DaLaura L.S. Kader, LLB, Vice President, Strategic Initiatives, Regenerative Medicine Foundation

David P. King, Chairman and Chief Executive Officer, LabCorp

Joachim Kohn, PhD, Director, New Jersey Center for Biomaterials

Scott Livingston, Chief Executive Officer, Livingston Securities, LLC

Peter T. Lomedico, PhD, Strategic Alliances & Industry Partnerships, JDRF

Thomas C. Meyers, JD, Partner, Brown Rudnick

Amy Miller, PhD, Public Policy Director, Personalized Medicine Coalition

C. Randal Mills, PhD, President and Chief Executive Officer, Osiris Therapeutics, Inc.

Lesa Mitchell, Vice President, Advancing Innovation, Ewing Marion Kauffman Foundation

George Muschler, MD, Vice-Chairman of the Department of Biomedical Engineering and Vice Chairman of the Orthopaedic and Rheumatologic Institute, Lerner Research Institute

Steven Nichtberger, MD, President and Chief Executive Officer, Tengion, Inc.

Mahendra Rao, MD, Vice President, R & D, Primary and Stem Cell Systems, Invitrogen, part of Life Technologies

Anthony Ratcliffe, PhD, President and Chief Executive Officer, Synthasome, Inc

Lieutenant General Eric B. Schoomaker, MD, PhD, The Surgeon General and Commanding General, US Army Medical Command

Vicki L. Seyfert-Margolis, PhD, Senior Advisory for Science, Innovation and Policy, US Food and Drug  Administration

Rosamund Smith, DPhil, Senior Research Advisor, Regenerative Biology, Biotechnology Discovery Research, Eli Lilly

Jay Tong, MD, President and Chief Executive Officer, AllCells

Rocky S. Tuan, PhD, Director, Center for Cellular and Molecular engineering, University of Pittsburgh School of Medicine 

Gil Van Bokkelen, PhD, Chairman and Chief Executive Officer, Athersys 

Andrew C. von Eschenbach, MD, Senior Director for Strategic Initiatives, Samaritan Health Initiatives 

Caleb Winder, Co-founder and Director, Excel Venture Management

Celia M. Witten, PhD, MD, Director of the Office of Cellular, Tissue and Gene Therapy, US Food and Drug Administration

Steven E. Wolf, MD, Chief, Clinical Research, United States Army Institute of Surgical Research